Guide for Authors


Guide for Authors



Scope of the Journal

General Policy

Article types

Ethical Consideration

Manuscript submission

Manuscript Preparation

Peer review process



Scope of the Journal

Journal of Basic and Clinical Oncology (JBCO) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer. JBCO would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication.


General Policy

Manuscripts, or details of their content, must not be previously published and should not be under simultaneous consideration by another Journal. By virtue of the submitted manuscript, the corresponding author acknowledges that all the co-authors have seen and approved the final version of the manuscript.The reviewing and publishing process depends on the quality of your study as well as the English language accuracy of your manuscript. A strong, scientifically-approved manuscript may be accepted in two to four weeks.

The editors consider that all submitted materials including text, figures or tables and any other file are original. If it is not the case, the authors must provide both print and online permission from the copyright owner. JBCO and the publisher will not be held legally responsible should there be any claims for compensation. The authors are responsible for the whole scientific content as well as the accuracy of the bibliographic information.

The editor-in-chief may reject manuscripts prior to peer review if they are beyond the scope of the journal or do not comply with the instructions for authors. Manuscripts are only accepted for publication on the assumption that the authors will permit editorial amendments, though proofs will always be submitted to the corresponding author before the final press submission. The decision to accept a contribution rests with the Editorial Board of the JBCO.


Publication fee

JBCO is free of charge for publication or processing.


Open access

All articles published in this Journal will be open access, which means, articles are universally and freely accessible via the Internet immediately after publication through  


Article types

The main article types will be considered for publication, are as follows:

Original articles: The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. Authors should not unnecessarily divide their work into several related manuscripts, although Short Communications of preliminary, but significant, results will be considered. Quality and impact of the study will be considered during peer review.

Case reports: Case reports present detailed information on the symptoms, signs, diagnosis, treatment (including all types of interventions), and outcomes of an individual patient. Case reports usually describe new or uncommon conditions that serve to enhance medical care or highlight diagnostic approaches.

Review articles: These provide concise and precise updates on the latest progress made in a given area of research. Systematic reviews should follow the PRISMA guidelines.

Meta-analyses: Meta-analysis Report combined results of individual studies, after a comprehensive search of the available database, using special statistical methods.


Ethical Consideration (adapted from COPE guidelines):

Study design and ethical approval: Good research should be well justified, well planned, appropriately designed, and ethically approved. To conduct research to a lower standard may constitute misconduct. The authors are responsible for the whole scientific content as well as the accuracy of the bibliographic information.

Data analysis: Data should be appropriately analyzed, but inappropriate analysis does not necessarily amount to misconduct. Fabrication and falsification of data do constitute misconduct.

Authorship: There is no universally agreed definition of authorship. As a minimum, authors should be responsible for a particular section of the study.

Acknowledgment: Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in the Acknowledgments section. Financial and material support should also be mentioned. Thanking anonymous reviewers is not sufficient.

Conflicts of interest: Conflicts of interest comprise those which may not be fully apparent and which may influence the judgment of authors, reviewers, and editors. They have been described as the ones which, when revealed later, would make a reasonable reader feel misled or deceived. They may be personal, commercial, political, academic or financial. “Financial” interests may include employment, research funding, stock or share ownership, payment for lectures or travel, consultancies and company support for staff.

Redundant publication: Redundant publication occurs when two or more papers, without full cross reference, share the same hypothesis, data, discussion points, or conclusions. In such cases, the manuscript will be rejected.

Plagiarism: Plagiarism ranges from the unreferenced use of others’ published and unpublished ideas, including research grant applications to submission under “new” authorship of a complete paper, sometimes in a different language. It may occur at any stage of planning, research, writing, or publication: it applies to print and electronic versions. All the manuscripts submitted to JBCO are checked by Ithenticate software for possible plagiarism. The authors are expected to check their manuscript for plagiarism before submission.


Manuscript Preparation

Manuscripts should be prepared in accordance with the “Uniform Requirements for Manuscripts Submission to Biomedical Journals” proclaimed by the International Committee of Medical Journal Editors (

Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

Manuscripts should be typed on A4 size paper in clear, concise English and double-spaced. Authors are requested to reserve margins of at least 2.5 cm all around the paper. Pages should be numbered consecutively starting with the title page.

Manuscripts should be kept to a minimum length and should be subdivided into labeled sections:

“Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement, Conflicts of interest, References, Figure legends, Tables”.

Title page: A title page is to be provided and should include the following in order : Title (please keep it short and informative), Full first name and surname (and middle name initials) of all authors, Affiliation (s) and e-mail address(es) of all authors, Corresponding author’s Full name, postal address, e-mail address, Telephone and Fax number(s). The "corresponding author" and "first author" must have an ORCID ID; if you do not have any, simply apply here. A short running title of fewer than 40 characters must be added at the end of the Title page.

Abstract: An abstract with a Maximum of 300 words for research articles and 250 words for reviews is to be provided as the second page. The abstract should be structured as Objective(s) (including purpose setting), Methods, Results, and Conclusion. The abstract of the review articles is not structured.

Keywords: A list of 3-6 keywords, preferably chosen from the Medical Subject Headings (MeSH) list, is to be provided directly below the abstract. Keywords should express the precise content of the manuscript, as they are used for indexing purposes. 


General Style Points: The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Numbers: Numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Figures: Figures and artworks should be submitted as separate files in JPG or TIFF format. Figures should be utilized only if they augment the understandability of the text. The same data should not be presented in tables, figures and text, simultaneously. Drawings and graphs should be professionally prepared with a minimum resolution of 300 DPI. If you include a figure from a previous publication, you must provide permission from the copyright owner(s) for both the print and online format Legends to Figures.   

Figure legends: Figure legends should be brief and specific and should not duplicate the body of the text. Each illustration must have a title and an explanatory legend. The title should be part of the legend and not reproduced on the figure itself. All symbols and abbreviations used in the figure including statistical information must be explained. The legends should be placed on a separate page at the end of the manuscript after references and begin with the number of the illustration they refer to. Name each figure with the word “Fig” followed by figure number without punctuation:  “Fig1”.

Tables: Cite tables consecutively in the text, and number them in that order. Tables should be self-explanatory and should supplement, rather than duplicate, the material in the text. Do not embed tables within the body of the manuscript. They should be placed on a separate page at the end of the manuscript after Figure legends. The captions should be placed above.

References: References should be numbered in the order in which they appear in the text (number in parentheses), preferably in limited numbers and up-to-date. Periodical titles should be abbreviated according to the PubMed Journals Database ( When there are six or fewer authors, print all their surnames and initials. . In the case of seven or more authors, the names of the first six authors followed by et al. (Italic) should be listed. References to a Journal, a chapter in a book and a book  are listed below in correct style, respectively (according to Vancouver style):


A. Journal article

 Standard format for print journal article:

Author(s) of article. Title of article. Abbreviated Title of Journal. Date of publication;vol(issue):page number(s).

 a) Example forJournal articles with 6 or fewer authors:

  Taghavi A, Mirfazaelian H, Shirian S, Aledavood A, Akhgar A. Cowden syndrome. Br J Hosp Med (Lond). 2018;79(6):352-3.

 b) Example for Journal articles with more than 6 authors:

 Ghobadi N, Mehramiz M, ShahidSales S, Rezaei Brojerdi A, Anvari K, Khazaei M, et al. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma. J Cell Physiol. 2019;234(4):5070-6.


B. Book

Standard Format for Citation to Whole Book:

Author(s) of book.  Title of book.  Edition (if other than first).  Place of publication: Publisher; Year of publication.


DeVita VT, Rosenberg SA, Lawrence TS. DeVita, Hellman, and Rosenberg's cancer, Principles & Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer; 2015.


C. Book chapter

a) Standard Format for a Chapter by the Book Author: This is a separately identified part of a book (i.e., you are not citing the whole book) which has been written by the author of the book himself/herself:

Author(s) of book.  Title of book.  Edition.  Place of publication: Publisher; Year of publication. Chapter number: Chapter title; inclusive pagination.


Perez CA, Brady LW.  Radiation oncology: management decisions. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2011.chapter 17: Oral cavity; p. 247-58.

b) Standard Format for a Chapter in an Edited Book: This is a separately identified part of a book which has been written by an author in a book edited by others:

Author(s) of chapter.  Title of chapter.  In:  Ed(s) name, ed(s).  Title of book.  Edition. Place of publication:  Publisher; Year of publication.  Inclusive pagination. 


Axibund JE, Willey EL. Genetic testing in pancreatic cancer. In: DeVita VT, Rosenberg SA, Lawrence TS, editors. DeVita, Hellman, and Rosenberg's cancer, Principles & Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer; 2015. p. 685-9. 


Peer review process

This journal uses Double-blind peer review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. All submissions will be reviewed anonymously by at least two independent referees. All manuscripts will be acknowledged upon presenting to the Journal office, provided that all stated requirements are met. Authors are encouraged to suggest names of three expert reviewers, but selection remains a prerogative of the Editor. The whole review process depends on receiving referees, comments and revising the manuscripts based on these comments to the author. On receipt of the revised article from the author, and after final approving by referees, the letter of acceptance is issued to the author. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest.



Proofs will be sent by email to the corresponding author as an attachment and should be corrected and returned promptly. Corrections should be kept to a minimum.